Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle

Gary D. Snyder, U. Murali Krishna, J. R. Falck, Arthur A. Spector

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Epoxyeicosatrienoic acids (EETs) are synthesized in the endothelial cells of vascular tissues. They are released from the endothelial cells and produce relaxation of the smooth muscle cells by hyperpolarization. The present findings demonstrate that EETs also regulate aromatase activity in vascular smooth muscle cells. Exposure of cultured rat aortic smooth muscle cells to either 1 μM 14,15-EET or 1 μM 11,12-EET inhibits dibutyryl cAMP-induced aromatase activity by 80-100%. 11,12-Dihydroxyeicosatrienoic acid, the hydration product of 11,12-EET, has no effect on dibutyryl cAMP-induced vascular smooth muscle aromatase activity. In contrast to 14,15-EET, the N-methylsulfanilamide derivative of 14,15-EET (14,15-EET-SA) was neither metabolized nor incorporated into cell lipids, but it retained the ability to inhibit cAMP-induced aromatase activity. Furthermore, the 14,15-EET-SA inhibition of cAMP-induced aromatase activity persisted when the sulfanilamide derivative of 14,15-EET was covalently tethered to silica beads (average diameter, 0.5 μm), which restricted 14,15-EET-SA from entering the cell. These data are consistent with the presence of a receptor for EETs in the plasma membrane and support the hypothesis that the inhibition of aromatase by EETs is initiated by the interaction of EET with the putative plasma membrane receptor.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume283
Issue number5 52-5
StatePublished - Nov 1 2002

Fingerprint

Aromatase
Vascular Smooth Muscle
Membranes
Smooth Muscle Myocytes
Endothelial Cells
Cell Membrane
14,15-epoxy-5,8,11-eicosatrienoic acid
Silicon Dioxide
Lipids
Acids

Keywords

  • Adenosine 3′,5′-cylic monophosphate
  • Epoxyeicosatrienoic acid
  • Estrogen
  • Receptor

ASJC Scopus subject areas

  • Physiology

Cite this

Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle. / Snyder, Gary D.; Murali Krishna, U.; Falck, J. R.; Spector, Arthur A.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 283, No. 5 52-5, 01.11.2002.

Research output: Contribution to journalArticle

@article{de159541f1bb4eceb9ff3a79c4bcd7d1,
title = "Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle",
abstract = "Epoxyeicosatrienoic acids (EETs) are synthesized in the endothelial cells of vascular tissues. They are released from the endothelial cells and produce relaxation of the smooth muscle cells by hyperpolarization. The present findings demonstrate that EETs also regulate aromatase activity in vascular smooth muscle cells. Exposure of cultured rat aortic smooth muscle cells to either 1 μM 14,15-EET or 1 μM 11,12-EET inhibits dibutyryl cAMP-induced aromatase activity by 80-100{\%}. 11,12-Dihydroxyeicosatrienoic acid, the hydration product of 11,12-EET, has no effect on dibutyryl cAMP-induced vascular smooth muscle aromatase activity. In contrast to 14,15-EET, the N-methylsulfanilamide derivative of 14,15-EET (14,15-EET-SA) was neither metabolized nor incorporated into cell lipids, but it retained the ability to inhibit cAMP-induced aromatase activity. Furthermore, the 14,15-EET-SA inhibition of cAMP-induced aromatase activity persisted when the sulfanilamide derivative of 14,15-EET was covalently tethered to silica beads (average diameter, 0.5 μm), which restricted 14,15-EET-SA from entering the cell. These data are consistent with the presence of a receptor for EETs in the plasma membrane and support the hypothesis that the inhibition of aromatase by EETs is initiated by the interaction of EET with the putative plasma membrane receptor.",
keywords = "Adenosine 3′,5′-cylic monophosphate, Epoxyeicosatrienoic acid, Estrogen, Receptor",
author = "Snyder, {Gary D.} and {Murali Krishna}, U. and Falck, {J. R.} and Spector, {Arthur A.}",
year = "2002",
month = "11",
day = "1",
language = "English (US)",
volume = "283",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5 52-5",

}

TY - JOUR

T1 - Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle

AU - Snyder, Gary D.

AU - Murali Krishna, U.

AU - Falck, J. R.

AU - Spector, Arthur A.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Epoxyeicosatrienoic acids (EETs) are synthesized in the endothelial cells of vascular tissues. They are released from the endothelial cells and produce relaxation of the smooth muscle cells by hyperpolarization. The present findings demonstrate that EETs also regulate aromatase activity in vascular smooth muscle cells. Exposure of cultured rat aortic smooth muscle cells to either 1 μM 14,15-EET or 1 μM 11,12-EET inhibits dibutyryl cAMP-induced aromatase activity by 80-100%. 11,12-Dihydroxyeicosatrienoic acid, the hydration product of 11,12-EET, has no effect on dibutyryl cAMP-induced vascular smooth muscle aromatase activity. In contrast to 14,15-EET, the N-methylsulfanilamide derivative of 14,15-EET (14,15-EET-SA) was neither metabolized nor incorporated into cell lipids, but it retained the ability to inhibit cAMP-induced aromatase activity. Furthermore, the 14,15-EET-SA inhibition of cAMP-induced aromatase activity persisted when the sulfanilamide derivative of 14,15-EET was covalently tethered to silica beads (average diameter, 0.5 μm), which restricted 14,15-EET-SA from entering the cell. These data are consistent with the presence of a receptor for EETs in the plasma membrane and support the hypothesis that the inhibition of aromatase by EETs is initiated by the interaction of EET with the putative plasma membrane receptor.

AB - Epoxyeicosatrienoic acids (EETs) are synthesized in the endothelial cells of vascular tissues. They are released from the endothelial cells and produce relaxation of the smooth muscle cells by hyperpolarization. The present findings demonstrate that EETs also regulate aromatase activity in vascular smooth muscle cells. Exposure of cultured rat aortic smooth muscle cells to either 1 μM 14,15-EET or 1 μM 11,12-EET inhibits dibutyryl cAMP-induced aromatase activity by 80-100%. 11,12-Dihydroxyeicosatrienoic acid, the hydration product of 11,12-EET, has no effect on dibutyryl cAMP-induced vascular smooth muscle aromatase activity. In contrast to 14,15-EET, the N-methylsulfanilamide derivative of 14,15-EET (14,15-EET-SA) was neither metabolized nor incorporated into cell lipids, but it retained the ability to inhibit cAMP-induced aromatase activity. Furthermore, the 14,15-EET-SA inhibition of cAMP-induced aromatase activity persisted when the sulfanilamide derivative of 14,15-EET was covalently tethered to silica beads (average diameter, 0.5 μm), which restricted 14,15-EET-SA from entering the cell. These data are consistent with the presence of a receptor for EETs in the plasma membrane and support the hypothesis that the inhibition of aromatase by EETs is initiated by the interaction of EET with the putative plasma membrane receptor.

KW - Adenosine 3′,5′-cylic monophosphate

KW - Epoxyeicosatrienoic acid

KW - Estrogen

KW - Receptor

UR - http://www.scopus.com/inward/record.url?scp=0036838633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036838633&partnerID=8YFLogxK

M3 - Article

VL - 283

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5 52-5

ER -